D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 65 Citations 14,346 274 World Ranking 1363 National Ranking 60
Medicine D-index 71 Citations 16,138 340 World Ranking 14522 National Ranking 450

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Cancer

His scientific interests lie mostly in Immunology, Cell biology, Cytotoxic T cell, T cell and Molecular biology. His research on Immunology frequently links to adjacent areas such as Cancer research. His Cell biology study combines topics from a wide range of disciplines, such as Semaphorin, Receptor and SEMA4D.

His research investigates the connection between Cytotoxic T cell and topics such as Toxic epidermal necrolysis that intersect with problems in Interleukin and Tumor necrosis factor alpha. The T cell study which covers Epitope that intersects with Glycoprotein. Armand Bensussan has included themes like Cell culture, Lymphoblast, CD72, B cell and Major histocompatibility complex in his Molecular biology study.

His most cited work include:

  • Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. (423 citations)
  • Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells (286 citations)
  • Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes. (249 citations)

What are the main themes of his work throughout his whole career to date?

Armand Bensussan focuses on Immunology, Molecular biology, Cancer research, T cell and Cytotoxic T cell. His is involved in several facets of Immunology study, as is seen by his studies on CD8, Immune system, Antibody, T lymphocyte and Antigen. Many of his studies on Antigen involve topics that are commonly interrelated, such as IL-2 receptor.

His Molecular biology research is multidisciplinary, relying on both Cell culture, T-cell receptor, Epitope, CD3 and Monoclonal antibody. His Cancer research research includes themes of Receptor, KIR3DL2, Cutaneous T-cell lymphoma and Lymphoma. His work in Cytotoxic T cell covers topics such as Cell biology which are related to areas like Cellular differentiation.

He most often published in these fields:

  • Immunology (51.15%)
  • Molecular biology (26.82%)
  • Cancer research (29.31%)

What were the highlights of his more recent work (between 2014-2021)?

  • Cancer research (29.31%)
  • Immunology (51.15%)
  • Internal medicine (9.00%)

In recent papers he was focusing on the following fields of study:

Armand Bensussan mainly investigates Cancer research, Immunology, Internal medicine, Immune system and KIR3DL2. His Cancer research study integrates concerns from other disciplines, such as Receptor, Cancer, Signal transduction and Antibody. In his research, CD8 and Monoclonal antibody is intimately related to T cell, which falls under the overarching field of Receptor.

His Antibody study incorporates themes from Molecular biology and MUC1. His Immunology research is multidisciplinary, incorporating perspectives in Dermis, Graft-versus-host disease and Cell biology. His Immune system research incorporates elements of Endometrium and Progenitor cell.

Between 2014 and 2021, his most popular works were:

  • Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity (106 citations)
  • Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies. (101 citations)
  • CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease (101 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Cancer

Armand Bensussan spends much of his time researching Cancer research, Immunology, Immune system, Internal medicine and Antibody. His studies in Cancer research integrate themes in fields like KIR3DL2, Signal transduction, Lymphoma and Immunotherapy. His study looks at the relationship between Signal transduction and topics such as Cell cycle, which overlap with Cell biology.

His work carried out in the field of Immunology brings together such families of science as Interleukin 12 and Graft-versus-host disease. His Immune system research includes themes of Endometrium and Antigen. His research investigates the connection between Immunosuppression and topics such as Effector that intersect with issues in Cytotoxic T cell.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8.

Sylvie Fournel;Maryse Aguerre-Girr;Xavier Huc;Françoise Lenfant.
Journal of Immunology (2000)

556 Citations

Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells

Amal Nassif;Armand Bensussan;Laurence Boumsell;Aurelien Deniaud.
The Journal of Allergy and Clinical Immunology (2004)

421 Citations

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

T Hercend;J D Griffin;A Bensussan;R E Schmidt.
Journal of Clinical Investigation (1985)

378 Citations

Drug Specific Cytotoxic T-Cells in the Skin Lesions of a Patient with Toxic Epidermal Necrolysis

Amal Nassif;Armand Bensussan;Guillaume Dorothée;Fathia Mami-Chouaib.
Journal of Investigative Dermatology (2002)

333 Citations

Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation.

Kathryn T. Hall;Laurence Boumsell;Joachim L. Schultze;Vassiliki A. Boussiotis.
Proceedings of the National Academy of Sciences of the United States of America (1996)

316 Citations

CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.

Jean-François Emile;Marie-Laure Boulland;Corinne Haioun;Panagiotis Kanavaros.
Blood (1996)

291 Citations

IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro.

Jean-David Bouaziz;Sebastien Calbo;Sebastien Calbo;Sebastien Calbo;Maud Maho-Vaillant;Maud Maho-Vaillant;Anne Saussine;Anne Saussine.
European Journal of Immunology (2010)

274 Citations

Biology and clinical applications

Salem Chouaib;Zohra Soua;Jean-Michel Mencia-Huerta;Armand Bensussan.
European Cytokine Network (2004)

254 Citations

The Human T-Cell Receptor

Oreste Acuto;Marina Fabbi;Armand Bensussan;Claudio Milanese.
Journal of Clinical Immunology (1985)

248 Citations

IFNα kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model

Daniel Zagury;Hélène Le Buanec;Alexis Mathian;Patrick Larcier.
Proceedings of the National Academy of Sciences of the United States of America (2009)

229 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Armand Bensussan

Edgardo D. Carosella

Edgardo D. Carosella

Université Paris Cité

Publications: 57

Atsushi Kumanogoh

Atsushi Kumanogoh

Osaka University

Publications: 50

Nathalie Rouas-Freiss

Nathalie Rouas-Freiss

French Alternative Energies and Atomic Energy Commission

Publications: 46

Dean J. Naisbitt

Dean J. Naisbitt

University of Liverpool

Publications: 42

Werner J. Pichler

Werner J. Pichler

University Hospital of Bern

Publications: 37

Hitoshi Kikutani

Hitoshi Kikutani

Osaka University

Publications: 33

Stuart F. Schlossman

Stuart F. Schlossman

Harvard University

Publications: 32

Ellis L. Reinherz

Ellis L. Reinherz

Harvard University

Publications: 29

Martine Bagot

Martine Bagot

Université Paris Cité

Publications: 27

B. Kevin Park

B. Kevin Park

University of Liverpool

Publications: 26

Jerome Ritz

Jerome Ritz

Harvard University

Publications: 25

Lorenzo Moretta

Lorenzo Moretta

Bambino Gesù Children's Hospital

Publications: 25

Luca Tamagnone

Luca Tamagnone

Catholic University of the Sacred Heart

Publications: 24

Gérard Chaouat

Gérard Chaouat

Inserm : Institut national de la santé et de la recherche médicale

Publications: 23

Jean Dausset

Jean Dausset

Inserm : Institut national de la santé et de la recherche médicale

Publications: 23

Alessandro Moretta

Alessandro Moretta

University of Genoa

Publications: 23

Trending Scientists

Xiao Qin

Xiao Qin

Auburn University

Rajesh Bordawekar

Rajesh Bordawekar

IBM (United States)

Alessio Ishizaka

Alessio Ishizaka

NEOMA Business School

Cassandra L. Fraser

Cassandra L. Fraser

University of Virginia

Derek R. Boyd

Derek R. Boyd

Queen's University Belfast

Takaharu Onishi

Takaharu Onishi

University of Tokyo

Dalila Pinto

Dalila Pinto

Icahn School of Medicine at Mount Sinai

Pim Lindhout

Pim Lindhout

Wageningen University & Research

Wolfgang Witte

Wolfgang Witte

Robert Koch Institute

David R. DeWalle

David R. DeWalle

Pennsylvania State University

William H. Merigan

William H. Merigan

University of Rochester

Nicholas C. Brecha

Nicholas C. Brecha

University of California, Los Angeles

Mingxiong Huang

Mingxiong Huang

University of California, San Diego

Robert E. Hawkins

Robert E. Hawkins

University of Manchester

Richard A. Morgan

Richard A. Morgan

National Institutes of Health

Janardan P. Pandey

Janardan P. Pandey

Medical University of South Carolina

Something went wrong. Please try again later.